Literature DB >> 28433836

Recent advances in diagnostic and therapeutic guidelines for primary and secondary hemophagocytic lymphohistiocytosis.

Smita Ramachandran1, Fauzia Zaidi2, Archana Aggarwal3, Rani Gera4.   

Abstract

BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory syndrome characterized by excessive activation of macrophages and T cells resulting from defective cytotoxicity. It is potentially life threatening due to the large amounts of cytokines released by the activated macrophages and lymphocytes secondary to a hyperinflammatory response. It has a high fatality in children with an incidence of approximately 1.2cases/million per year.
METHOD: The literature was extensively searched in PubMed, MEDLINE and Google scholar.
RESULTS: A variable and nonspecific symptomatology can delay the diagnosis and hence requires a high index of suspicion in both primary and secondary HLH.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Children; Fibrous cortical dysplasia; Hemophagocytic lymphohistiocytosis

Mesh:

Substances:

Year:  2016        PMID: 28433836     DOI: 10.1016/j.bcmd.2016.10.023

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  8 in total

1.  Hemophagocytic lymphohistiocytosis in a child with chronic granulomatous disease: A rare complication of a rare disorder.

Authors:  Gitanjali Jain; Suprita Kalra; Saurabh Sharma; Gautam Kumar Vasnik; Rakesh Gupta
Journal:  Med J Armed Forces India       Date:  2019-04-15

2.  A nine-month-old-boy with Atypical Hemophagocytic Lymphohistiocytosis.

Authors:  Monia Ouederni; Monia Ben Khaled; Samia Rekaya; Ilhem Ben Fraj; Fethi Mellouli; Mohamed Bejaoui
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-10-16       Impact factor: 2.576

Review 3.  Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?

Authors:  Violetta Opoka-Winiarska; Ewelina Grywalska; Jacek Roliński
Journal:  BMC Med       Date:  2020-07-15       Impact factor: 8.775

Review 4.  The unique characteristics of COVID-19 coagulopathy.

Authors:  Toshiaki Iba; Jerrold H Levy; Jean Marie Connors; Theodore E Warkentin; Jecko Thachil; Marcel Levi
Journal:  Crit Care       Date:  2020-06-18       Impact factor: 9.097

Review 5.  Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective.

Authors:  Choongho Lee; Won Jun Choi
Journal:  Arch Pharm Res       Date:  2021-01-04       Impact factor: 6.010

6.  Acute fibrinous and organizing pneumonia complicated with hemophagocytic lymphohistiocytosis caused by chronic active Epstein-Barr virus infection: a case report.

Authors:  Xiaojing Wu; Kejing Wang; Yayue Gao; Ying Cai; Wenqiao Wang; Dingrong Zhong; Qingyuan Zhan
Journal:  BMC Infect Dis       Date:  2021-12-04       Impact factor: 3.090

Review 7.  Hemophagocytic lymphohistiocytosis in an adult kidney transplant recipient successfully treated by plasmapheresis: A case report and review of the literature.

Authors:  Christian Nusshag; Christian Morath; Martin Zeier; Markus A Weigand; Uta Merle; Thorsten Brenner
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

8.  Hepatic sinusoidal hemophagocytosis with and without hemophagocytic lymphohistiocytosis.

Authors:  Jacqueline De Gottardi; Matteo Montani; Anne Angelillo-Scherrer; Alicia Rovo; Annalisa Berzigotti
Journal:  PLoS One       Date:  2019-12-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.